What are the requirements for applying for Class D medical device MDACS registration in Hong Kong?
Release time:2025-07-08 15:30:43 The author: source:
To apply for Class D medical device registration under the MDACS (Medical Device Administrative Control System) in Hong Kong, you must meet a series of regulatory, technical, and procedural requirements. Class D represents the highest-risk category, including life-supporting, implantable, or critical treatment devices (e.g., pacemakers, heart valves, dialysis systems).

To apply for Class D medical device registration under the MDACS (Medical Device Administrative Control System) in Hong Kong, you must meet a series of regulatory, technical, and procedural requirements. Class D represents the highest-risk category, including life-supporting, implantable, or critical treatment devices (e.g., pacemakers, heart valves, dialysis systems).

Below is a detailed list of requirements for Class D medical device MDACS registration in Hong Kong:


🔍 I. Regulatory Eligibility Requirements

1. Local Responsible Person (LRP)

  • Must be appointed if the manufacturer is not based in Hong Kong.

  • Must be a registered business in Hong Kong.

  • The LRP is responsible for:

    • Submitting the MDACS application

    • Post-market surveillance

    • Vigilance reporting (e.g. adverse events, recalls)

    • Communication with the Medical Device Division (MDD)


📦 II. Device Classification

  • You must confirm your device is Class D using:

    • Technical Reference TR-003 (for general medical devices)

    • Technical Reference TR-006 (for IVD devices)

  • Class D includes:

    • Devices in direct contact with the heart or central circulatory system

    • Devices that sustain life or prevent life-threatening conditions

    • Implantable and critical devices


📁 III. Required Documents for Application

✅ A. Application Form

  • MD 1 Form for general medical devices

  • MD 100 series for IVDs (if applicable)

  • Must be submitted via the MDIS online system (paper applications no longer accepted after October 2024)

✅ B. Declaration of Conformity

  • Must show compliance with Essential Principles of Safety and Performance (see GN-01 and GN-02)

  • Includes a signed statement from the manufacturer

✅ C. Regulatory Approval in GHTF Country

You must provide:

  • Certificate of Free Sale (CFS) or equivalent approval from at least one of the following:

    • EU (CE certificate)

    • USA (FDA 510(k) or PMA)

    • Canada (Health Canada MDL)

    • Australia (TGA ARTG)

    • Japan (PMDA or MHLW)

    • China (NMPA)

    • South Korea (MFDS)

    • Singapore (HSA)

✅ D. Quality Management System (QMS)

  • Valid ISO 13485:2016 certificate issued by an accredited notified body

  • QMS must cover the entire production process for the device

✅ E. Risk Management Report

  • Must comply with ISO 14971

  • Should include:

    • Risk analysis

    • Mitigation strategies

    • Residual risk evaluation

✅ F. Clinical Evaluation Report (CER)

  • Required for high-risk Class D devices

  • Can include:

    • Clinical trials

    • Literature review

    • Equivalence to existing approved devices

✅ G. Technical Documentation Summary

  • Device description (design, mechanism of action, components)

  • Manufacturing process overview

  • Software documentation (if applicable)

  • Sterilization process details (if applicable)

✅ H. Labeling and Instructions for Use (IFU)

  • Must be in English and/or Traditional Chinese

  • Include:

    • Intended use

    • Contraindications

    • Warnings and precautions

    • Manufacturer and LRP details

    • UDI (if applicable)

✅ I. Post-Market Surveillance Plan

  • Must describe:

    • Monitoring procedures

    • Adverse event reporting system

    • Field safety corrective action (FSCA) plan

    • Device recall procedures

    • Customer complaint handling system

✅ J. Other Supporting Documents

Depending on device type:

  • Biocompatibility testing results (per ISO 10993)

  • Electrical safety reports (IEC 60601 series)

  • EMC test reports

  • Software validation (for software-driven devices)

  • Sterility and shelf life validation


📤 IV. Submission via MDIS (Medical Device Information System)

  • All documents must be submitted through the MDIS online platform: https://www.mdd.gov.hk

  • LRP must register an account and manage submissions


🕓 V. Review Process

PhaseEstimated Time
Initial screening2–4 weeks
Technical document review3–6 months
Supplementary informationAs needed
Listing issuanceUpon approval

Total timeline may range from 3 to 9 months, depending on complexity and completeness.


📌 Summary: Key Requirements Checklist

Requirement TypeDescription
✅ Local Responsible PersonHK-registered legal entity
✅ Application FormMD1 (online via MDIS)
✅ Declaration of ConformityGN-01 / GN-02 principles
✅ Foreign ApprovalCFS / CE / FDA / TGA etc.
✅ ISO 13485 QMSFor device manufacture
✅ Risk Management ReportISO 14971
✅ Clinical EvaluationLiterature / trials
✅ Technical DocumentationProduct design & function
✅ Labeling & IFUEnglish & Traditional Chinese
✅ PMS PlanPost-market compliance plan

📎 Tips for Success

  • Ensure all foreign certificates (FDA/CE) are valid and current

  • Labeling must match the device model and intended use exactly

  • Prepare to respond quickly to MDD’s requests for clarification

  • Maintain traceability from manufacturer to Hong Kong distributor

  • Retain all documents and distribution records for inspection

laboratory-563423_1280.jpg

Contact Us:

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn